[Experimental and clinical data on the antitumor action of hydrazine sulfate]

Vopr Onkol. 1975;21(1):45-52.
[Article in Russian]
No abstract available

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adult
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma 256, Walker / drug therapy
  • Carcinoma, Ehrlich Tumor / drug therapy
  • Carcinoma, Squamous Cell / drug therapy
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Female
  • Hodgkin Disease / drug therapy
  • Humans
  • Hydrazines / administration & dosage
  • Hydrazines / therapeutic use*
  • Hydrazines / toxicity
  • Lethal Dose 50
  • Leukemia, Experimental / drug therapy
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Neoplasms / drug therapy
  • Neoplasms, Experimental / drug therapy
  • Rats
  • Sarcoma 37 / drug therapy
  • Skin Neoplasms / drug therapy
  • Sulfates / therapeutic use
  • Time Factors

Substances

  • Antineoplastic Agents
  • Hydrazines
  • Sulfates